Bedaquiline 100 mg (Generic)

edaquiline 100 mg (Generic) is a diarylquinoline-class antimicrobial agent specifically designed to combat multidrug-resistant tuberculosis (MDR-TB). It works by inhibiting mycobacterial ATP synthase, an essential enzyme required for energy production in Mycobacterium tuberculosis, thereby preventing bacterial growth and survival.

This medicine is prescribed as part of a combination therapy regimen under strict medical supervision. It is usually reserved for cases where conventional anti-TB drugs are ineffective. Bedaquiline helps improve treatment outcomes in MDR-TB patients when taken regularly and as directed by a healthcare provider.

Key Features:

• Active ingredient: Bedaquiline fumarate equivalent to 100 mg Bedaquiline

• Indicated for: Multidrug-resistant tuberculosis (MDR-TB)

• Mechanism: Inhibits ATP synthase of M. tuberculosis

• Form: Oral tablet

• Use: Always as part of a combination therapy with other TB medicines under medical guidance

Note: Bedaquiline should only be taken under the supervision of a qualified physician experienced in MDR-TB management. Misuse may lead to resistance or serious side effects.